469 related articles for article (PubMed ID: 21320969)
1. Autosomal recessive best vitelliform macular dystrophy: report of a family and management of early-onset neovascular complications.
Iannaccone A; Kerr NC; Kinnick TR; Calzada JI; Stone EM
Arch Ophthalmol; 2011 Feb; 129(2):211-7. PubMed ID: 21320969
[TBL] [Abstract][Full Text] [Related]
2. A homozygous frameshift mutation in BEST1 causes the classical form of Best disease in an autosomal recessive mode.
Bitner H; Mizrahi-Meissonnier L; Griefner G; Erdinest I; Sharon D; Banin E
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5332-8. PubMed ID: 21467170
[TBL] [Abstract][Full Text] [Related]
3. Ranibizumab for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy: one-year results.
Mimoun G; Caillaux V; Querques G; Rothschild PR; Puche N; Souied EH
Retina; 2013 Mar; 33(3):513-21. PubMed ID: 23400081
[TBL] [Abstract][Full Text] [Related]
4. Best vitelliform macular dystrophy in a Swedish family: genetic analysis and a seven-year follow-up of photodynamic treatment of a young boy with choroidal neovascularization.
Frennesson CI; Wadelius C; Nilsson SE
Acta Ophthalmol; 2014 May; 92(3):238-42. PubMed ID: 23617333
[TBL] [Abstract][Full Text] [Related]
5. Use of Intravitreal Bevacizumab in a 9-Year-Old Child with Choroidal Neovascularization Associated with Autosomal Recessive Bestrophinopathy.
Hussain RN; Shahid FL; Empeslidis T; Ch'ng SW
Ophthalmic Genet; 2015; 36(3):265-9. PubMed ID: 25265375
[TBL] [Abstract][Full Text] [Related]
6. A NOVEL P.ASP304GLY MUTATION IN BEST1 GENE ASSOCIATED WITH ATYPICAL BEST VITELLIFORM MACULAR DYSTROPHY PHENOTYPE AND HIGH INTRAFAMILIAL VARIABILITY.
Peiretti E; Caminiti G; Forma G; Carboni G; Dhaenens CM; Querques L; Souied E; Querques G
Retina; 2016 Sep; 36(9):1733-40. PubMed ID: 26807628
[TBL] [Abstract][Full Text] [Related]
7. Novel Mutation in BEST1 Associated with Atypical Best Vitelliform Dystrophy.
Matson ME; Ly SV; Monarrez JL
Optom Vis Sci; 2015 Aug; 92(8):e180-9. PubMed ID: 26099059
[TBL] [Abstract][Full Text] [Related]
8. Near-infrared fundus autofluorescence in subclinical best vitelliform macular dystrophy.
Parodi MB; Iacono P; Del Turco C; Bandello F
Am J Ophthalmol; 2014 Dec; 158(6):1247-1252.e2. PubMed ID: 25174897
[TBL] [Abstract][Full Text] [Related]
9. A novel variant of autosomal recessive best vitelliform macular dystrophy and management of early-onset complications.
Albuainain A; Alhatlan HM; Alkhars W
Saudi J Ophthalmol; 2021; 35(2):159-163. PubMed ID: 35391813
[TBL] [Abstract][Full Text] [Related]
10. Autosomal dominant Best disease with an unusual electrooculographic light rise and risk of angle-closure glaucoma: a clinical and molecular genetic study.
Low S; Davidson AE; Holder GE; Hogg CR; Bhattacharya SS; Black GC; Foster PJ; Webster AR
Mol Vis; 2011; 17():2272-82. PubMed ID: 21921978
[TBL] [Abstract][Full Text] [Related]
11. Novel BEST1 Mutations and Special Clinical Features of Best Vitelliform Macular Dystrophy.
Liu J; Zhang Y; Xuan Y; Liu W; Wang M
Ophthalmic Res; 2016; 56(4):178-185. PubMed ID: 27078032
[TBL] [Abstract][Full Text] [Related]
12. Autosomal recessive vitelliform macular dystrophy in a large cohort of vitelliform macular dystrophy patients.
Kinnick TR; Mullins RF; Dev S; Leys M; Mackey DA; Kay CN; Lam BL; Fishman GA; Traboulsi E; Iezzi R; Stone EM
Retina; 2011 Mar; 31(3):581-95. PubMed ID: 21273940
[TBL] [Abstract][Full Text] [Related]
13. The spectrum of subclinical Best vitelliform macular dystrophy in subjects with mutations in BEST1 gene.
Querques G; Zerbib J; Santacroce R; Margaglione M; Delphin N; Querques L; Rozet JM; Kaplan J; Souied EH
Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4678-84. PubMed ID: 21436265
[TBL] [Abstract][Full Text] [Related]
14. Frequency and clinical pattern of vitelliform macular dystrophy caused by mutations of interphotoreceptor matrix IMPG1 and IMPG2 genes.
Meunier I; Manes G; Bocquet B; Marquette V; Baudoin C; Puech B; Defoort-Dhellemmes S; Audo I; Verdet R; Arndt C; Zanlonghi X; Le Meur G; Dhaenens CM; Hamel CP
Ophthalmology; 2014 Dec; 121(12):2406-14. PubMed ID: 25085631
[TBL] [Abstract][Full Text] [Related]
15. Functional and anatomic changes in bilateral choroidal neovascularization associated with vitelliform macular dystrophy after intravitreal bevacizumab.
Cennamo G; Cesarano I; Vecchio EC; Reibaldi M; de Crecchio G
J Ocul Pharmacol Ther; 2012 Dec; 28(6):643-6. PubMed ID: 22742532
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab treatment for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy.
Tiosano L; Jaouni T; Averbukh E; Grunin M; Banin E; Chowers I
Eur J Ophthalmol; 2014; 24(6):890-6. PubMed ID: 24846624
[TBL] [Abstract][Full Text] [Related]
17. Unilateral vitelliform phenotype in autosomal recessive bestrophinopathy.
Cascavilla ML; Querques G; Stenirri S; Battaglia Parodi M; Querques L; Bandello F
Ophthalmic Res; 2012; 48(3):146-50. PubMed ID: 22584882
[TBL] [Abstract][Full Text] [Related]
18. [Intravitreal bevacizumab treatment for choroidal neovascularization in Best's disease].
Perol J; Wolff B; Sahel JA; Le Mer Y
J Fr Ophtalmol; 2011 May; 34(5):281-6. PubMed ID: 21507509
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child.
Chhablani J; Jalali S
Eur J Ophthalmol; 2012; 22(4):677-9. PubMed ID: 22139615
[TBL] [Abstract][Full Text] [Related]
20. Frequency, genotype, and clinical spectrum of best vitelliform macular dystrophy: data from a national center in Denmark.
Bitner H; Schatz P; Mizrahi-Meissonnier L; Sharon D; Rosenberg T
Am J Ophthalmol; 2012 Aug; 154(2):403-412.e4. PubMed ID: 22633354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
